Xuan Yang

2.2k total citations · 1 hit paper
34 papers, 1.3k citations indexed

About

Xuan Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuan Yang has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuan Yang's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (6 papers). Xuan Yang is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (6 papers). Xuan Yang collaborates with scholars based in China, Ethiopia and United States. Xuan Yang's co-authors include Chuanyuan Wei, Rui Peng, Pengfei Zhang, Jia‐Cheng Lu, Jia Fan, Ai‐Wu Ke, Chao Gao, Guo‐Ming Shi, Xiaoyong Huang and Jiabin Cai and has published in prestigious journals such as Oncogene, Journal of Neurochemistry and Journal of Hepatology.

In The Last Decade

Xuan Yang

33 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma

2022 114 citations Chuanyuan Wei, Meng-Xuan Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuan Yang China	20	898	672	204	148	137	34	1.3k
Ling Gu China	22	1.0k 1.2×	485 0.7×	395 1.9×	202 1.4×	99 0.7×	57	1.4k
Huahong Xie China	22	812 0.9×	441 0.7×	249 1.2×	69 0.5×	98 0.7×	43	1.1k
Ashley M. Mohr United States	13	859 1.0×	753 1.1×	162 0.8×	168 1.1×	117 0.9×	16	1.3k
Mingxuan Feng China	16	857 1.0×	488 0.7×	210 1.0×	102 0.7×	126 0.9×	48	1.3k
Pengcheng Jiang China	24	1.4k 1.5×	1.1k 1.7×	151 0.7×	149 1.0×	203 1.5×	59	1.8k
Jun Song China	23	990 1.1×	675 1.0×	449 2.2×	175 1.2×	115 0.8×	69	1.6k
Zhongwei Lv China	20	784 0.9×	372 0.6×	191 0.9×	96 0.6×	80 0.6×	51	1.2k
Jiang Zhu China	21	692 0.8×	515 0.8×	177 0.9×	75 0.5×	110 0.8×	75	1.2k

Countries citing papers authored by Xuan Yang

Since Specialization

Citations

This map shows the geographic impact of Xuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Yang more than expected).

Fields of papers citing papers by Xuan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Yang. The network helps show where Xuan Yang may publish in the future.

Co-authorship network of co-authors of Xuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Yang. A scholar is included among the top collaborators of Xuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Yang. Xuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Shiqiang, et al.. (2025). Satellite retrievals of total phosphorus in Taihu Lake using Sentinel-2 images and an optimized XGBoost model. Ecological Indicators. 175. 113563–113563. 2 indexed citations

Zhang, Yulong, et al.. (2024). Non-coding RNA and drug resistance in head and neck cancer. Cancer Drug Resistance. 7. 34–34. 4 indexed citations

Guo, Xiaojun, Xiaoyong Huang, Xuan Yang, et al.. (2023). Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell Death and Disease. 14(2). 79–79. 14 indexed citations

Yang, Xuan, et al.. (2023). ALDOB plays a tumor-suppressive role by inhibiting AKT activation in gastric cancer. Journal of Cancer. 14(12). 2255–2262. 5 indexed citations

Fu, Lei, et al.. (2023). MiR‐526b targets lncRNA SLC16A1‐AS1 to suppress cell proliferation in triple‐negative breast cancer. Journal of Biochemical and Molecular Toxicology. 37(3). e23247–e23247. 2 indexed citations

Yang, Xuan, et al.. (2021). Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer. World Journal of Surgical Oncology. 19(1). 248–248. 20 indexed citations

Huang, Xiaoyong, Pengfei Zhang, Chuanyuan Wei, et al.. (2020). Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Molecular Cancer. 19(1). 92–92. 178 indexed citations

Yang, Xuan, et al.. (2019). LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1. Cancer Biotherapy and Radiopharmaceuticals. 34(10). 671–675. 18 indexed citations

Peng, Rui, Pengfei Zhang, Xuan Yang, et al.. (2019). Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 113–113. 45 indexed citations

10.

Wei, Chuanyuan, Meng-Xuan Zhu, Yanwen Yang, et al.. (2019). Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma. Journal of Hematology & Oncology. 12(1). 21–21. 122 indexed citations

11.

Wang, Ying‐Chih, Xuan Yang, Wenbin Wei, & Xiaolin Xu. (2018). Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein. International Journal of Ophthalmology. 11(8). 1258–1268. 20 indexed citations

12.

Yang, Xuan, Jiabin Cai, Rui Peng, et al.. (2018). The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p. Journal of Cellular Physiology. 234(7). 12051–12060. 40 indexed citations

13.

Yang, Xuan, Yang Li, Xiaolin Xu, et al.. (2018). Novel circular RNA expression profile of uveal melanoma revealed by microarray. Chinese Journal of Cancer Research. 30(6). 656–668. 19 indexed citations

14.

Wei, Chuanyuan, Meng-Xuan Zhu, Nanhang Lu, et al.. (2018). Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma. Oncogene. 38(11). 1876–1891. 42 indexed citations

15.

Yang, Xuan, Yuzhang Wu, Bei Zhang, & Bing Ni. (2018). Noncoding RNAs in multiple sclerosis. Clinical Epigenetics. 10(1). 149–149. 46 indexed citations

16.

He, Tao, Yifan Chi, Hongyan Dai, et al.. (2017). Role of Jagged1-Hey1 Signal in Angiotensin II-induced Impairment of Myocardial Angiogenesis. Chinese Medical Journal. 130(3). 328–333. 5 indexed citations

17.

Peng, Rui, Xiaoyong Huang, Chi Zhang, et al.. (2017). Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance. OncoTargets and Therapy. Volume 10. 5863–5872. 18 indexed citations

18.

Xie, Nan, Jiabin Cai, Lu Zhang, et al.. (2017). Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Cell Death and Disease. 8(12). 3205–3205. 38 indexed citations

19.

Wang, Peng, Jia Liang, Yun Li, et al.. (2014). Down-Regulation of miRNA-30a Alleviates Cerebral Ischemic Injury Through Enhancing Beclin 1-Mediated Autophagy. Neurochemical Research. 39(7). 1279–1291. 121 indexed citations

20.

Bu, Xiangning, Nan Zhang, Xuan Yang, et al.. (2011). Proteomic analysis of cPKCβII‐interacting proteins involved in HPC‐induced neuroprotection against cerebral ischemia of mice. Journal of Neurochemistry. 117(2). 346–356. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Gu Breakdown of academic impact, for papers by Huahong Xie Breakdown of academic impact, for papers by Ashley M. Mohr Breakdown of academic impact, for papers by Mingxuan Feng Breakdown of academic impact, for papers by Pengcheng Jiang Breakdown of academic impact, for papers by Jun Song Breakdown of academic impact, for papers by Zhongwei Lv Breakdown of academic impact, for papers by Jiang Zhu